The role of kisspeptin/neurokinin B/dynorphin neurons in pathomechanism of vasomotor symptoms in postmenopausal women: from physiology to potential therapeutic applications

References

• Cray LA, Woods NF, Mitchell ES. Identifying symptom clusters during the menopausal transition: observations from the Seattle Midlife Women’s Health Study. Climacteric. 2013;16:539–549.
   PubMed Web of Science ®Google Scholar
• Carpenter JS, Woods NF, Otte JL. MsFLASH participants’ priorities for alleviating menopausal symptoms. Climacteric. 2015;18:859–866.
   PubMed Web of Science ®Google Scholar
• Greenblum CA, Rowe MA, Neff DF, et al. Midlife women: symptoms associated with menopausal transition and early postmenopause and quality of life. Menopause. 2013;20:22–27.
   PubMed Web of Science ®Google Scholar
• Hedrick RE, Ackerman RT, Koltun WD, et al. Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women. Menopause. 2009;16:132–140.
   PubMed Web of Science ®Google Scholar
• Stearns V, Ullmer L, López JF, et al. Hot flushes. Lancet. 2002;360:1851–1861.
   PubMed Web of Science ®Google Scholar
• Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015;175:531–539.
   PubMed Web of Science ®Google Scholar
• Bachmann GA. Vasomotor flushes in menopausal women. Am J Obstet Gynecol. 1999;180:S312–S316.
   PubMed Web of Science ®Google Scholar
• Cejudo Roman A, Pinto FM, Dorta I, et al. Analysis of the expression of neurokinin B, kisspeptin, and their cognate receptors NK3R and KISS1R in the human female genital tract. Fertil Steril. 2012;97:1213–1219.
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA. 2002;288:321–333.
   PubMed Web of Science ®Google Scholar
• Canonico M, Oger E, Plu-Bureau G, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation. 2007;115:840–845.
   PubMed Web of Science ®Google Scholar
• Modena MG, Sismondi P, Mueck AO, et al. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits. Maturitas. 2005;52:1–10.
   PubMed Web of Science ®Google Scholar
• Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet. 1997;350:1047–1059.
   PubMed Web of Science ®Google Scholar
• Gordon PR, Kerwin JP, Boesen KG, et al. Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population. Menopause. 2006;13:568–575.
   PubMed Web of Science ®Google Scholar
• Orleans RJ, Li L, Kim M-J, et al. FDA approval of paroxetine for menopausal hot flushes. N Engl J Med. 2014;370:1777–1779.
   PubMed Web of Science ®Google Scholar
• Davari-Tanha F, Soleymani-Farsani M, Asadi M, et al. Comparison of citalopram and venlafaxine’s role in treating sleep disturbances in menopausal women, a randomized, double-blind, placebo-controlled trial. Arch Gynecol Obstet. 2016;293:1007–1013.
   PubMed Web of Science ®Google Scholar
• Freeman EW, Guthrie KA, Caan B, et al. Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. JAMA. 2011;305:267.
   PubMed Web of Science ®Google Scholar
• Joffe H, Guthrie KA, LaCroix AZ, et al. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms. JAMA Intern Med. 2014;174:1058.
   PubMed Web of Science ®Google Scholar
• Franco OH, Chowdhury R, Troup J, et al. Use of plant-based therapies and menopausal symptoms: a systematic review and meta-analysis. JAMA. 2016;315:2554.
   PubMed Web of Science ®Google Scholar
• Atema V, van Leeuwen M, Oldenburg HSA, et al. An internet-based cognitive behavioral therapy for treatment-induced menopausal symptoms in breast cancer survivors. Menopause. 2017;24:762–767.
   PubMed Web of Science ®Google Scholar
• Ayers B, Smith M, Hellier J, et al. Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2). Menopause J North Am Menopause Soc. 2012;19:749–759.
   PubMed Web of Science ®Google Scholar
• Meczekalski B, Podfigurna-Stopa A, Warenik-Szymankiewicz A, et al. Functional hypothalamic amenorrhea: current view on neuroendocrine aberrations. Gynecol Endocrinol. 2008;24:4–11.
   PubMed Web of Science ®Google Scholar
• Hrabovszky E, Ciofi P, Vida B, et al. The kisspeptin system of the human hypothalamus: sexual dimorphism and relationship with gonadotropin-releasing hormone and neurokinin B neurons. Eur J Neurosci. 2010;31:1984–1998.
   PubMed Web of Science ®Google Scholar
• Navarro VM, Gottsch ML, Chavkin C, et al. Regulation of gonadotropin-releasing hormone secretion by kisspeptin/dynorphin/neurokinin B neurons in the arcuate nucleus of the mouse. J Neurosci. 2009;29:11859–11866.
   PubMed Web of Science ®Google Scholar
• True C, Kirigiti M, Ciofi P, et al. Characterisation of arcuate nucleus kisspeptin/neurokinin B neuronal projections and regulation during lactation in the rat. J Neuroendocrinol. 2011;23:52–64.
   PubMed Web of Science ®Google Scholar
• Skorupskaite K, George JT, Anderson RA. The kisspeptin-GnRH pathway in human reproductive health and disease. Hum Reprod Update. 2014;20:485–500.
   PubMed Web of Science ®Google Scholar
• Lehman MN, Coolen LM, Goodman RL. Minireview: kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: a central node in the control of gonadotropin-releasing hormone secretion. Endocrinology. 2010;151:3479–3489.
   PubMed Web of Science ®Google Scholar
• Herbison AE, de Tassigny X. dAnglemont, Doran J, et al. Distribution and postnatal development of Gpr54 gene expression in mouse brain and gonadotropin-releasing hormone neurons. Endocrinology 2010;151:312–321.
   PubMed Web of Science ®Google Scholar
• Krajewski SJ, Anderson MJ, Iles-Shih L, et al. Morphologic evidence that neurokinin B modulates gonadotropin-releasing hormone secretion via neurokinin 3 receptors in the rat median eminence. J Comp Neurol. 2005;489:372–386.
   PubMed Web of Science ®Google Scholar
• Herbison AE. Estrogen positive feedback to gonadotropin-releasing hormone (GnRH) neurons in the rodent: the case for the rostral periventricular area of the third ventricle (RP3V). Brain Res Rev. 2008;57:277–287.
   PubMedGoogle Scholar
• Gaskins GT, Glanowska KM, Moenter SM. Activation of neurokinin 3 receptors stimulates GnRH release in a location-dependent but kisspeptin-independent manner in adult mice. Endocrinology. 2013;154:3984–3989.
   PubMed Web of Science ®Google Scholar
• Nejad SZ, Tehrani FR, Zadeh-Vakili A, et al. The role of kisspeptin in female reproduction. Int J Endocrinol Metab. 2017;15:e44337.
   PubMed Web of Science ®Google Scholar
• Skorupskaite K, George JT, Veldhuis JD, et al. Interactions between neurokinin B and kisspeptin in mediating estrogen feedback in healthy women. J Clin Endocrinol Metab. 2016;101:4628–4636.
   PubMed Web of Science ®Google Scholar
• Smith JT, Popa SM, Clifton DK, et al. Kiss1 neurons in the forebrain as central processors for generating the preovulatory luteinizing hormone surge. J Neurosci. 2006;26:6687–6694.
   PubMed Web of Science ®Google Scholar
• Smith JT, Rao A, Pereira A, et al. Kisspeptin is present in ovine hypophysial portal blood but does not increase during the preovulatory luteinizing hormone surge: evidence that gonadotropes are not direct targets of kisspeptin in vivo. Endocrinology. 2008;149:1951–1959.
   PubMed Web of Science ®Google Scholar
• Micevych PE, Chaban V, Ogi J, et al. Estradiol stimulates progesterone synthesis in hypothalamic astrocyte cultures. Endocrinology. 2007;148:782–789.
   PubMed Web of Science ®Google Scholar
• Mittelman-Smith MA, Wong AM, Micevych PE. Estrogen and progesterone integration in an in vitro model of RP3V kisspeptin neurons. Neuroendocrinology. 2017;106:101–115.
   PubMed Web of Science ®Google Scholar
• Lee JH, Miele ME, Hicks DJ, et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst. 1996;88:1731–1737.
   PubMed Web of Science ®Google Scholar
• Messager S, Chatzidaki EE, Ma D, et al. Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. Proc Natl Acad Sci. 2005;102:1761–1766.
   PubMed Web of Science ®Google Scholar
• Topaloglu AK, Tello JA, Kotan LD, et al. Inactivating KISS1 mutation and hypogonadotropic hypogonadism. N Engl J Med. 2012;366:629–635.
   PubMed Web of Science ®Google Scholar
• Severini C, Improta G, Falconieri-Erspamer G, et al. The tachykinin peptide family. Pharmacol Rev. 2002;54:285–322.
   PubMed Web of Science ®Google Scholar
• Rance NE, Krajewski SJ, Smith MA, et al. Neurokinin B and the hypothalamic regulation of reproduction. Brain Res. 2010;1364:116.
   PubMed Web of Science ®Google Scholar
• Young J, George JT, Tello JA, et al. Kisspeptin restores pulsatile LH secretion in patients with neurokinin B signaling deficiencies: physiological, pathophysiological and therapeutic implications. Neuroendocrinology. 2013;97:193–202.
   PubMed Web of Science ®Google Scholar
• Navarro VM. Interactions between kisspeptins and neurokinin B. Adv Exp Med Biol. 2013;784:325–347.
   PubMed Web of Science ®Google Scholar
• Abacı A, Çatlı G, Anık A, et al. Significance of serum neurokinin B and kisspeptin levels in the differential diagnosis of premature thelarche and idiopathic central precocious puberty. Peptides. 2015;64:29–33.
   PubMed Web of Science ®Google Scholar
• Topaloglu AK, Reimann F, Guclu M, et al. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for neurokinin B in the central control of reproduction. Nat Genet. 2009;41:354–358.
   PubMed Web of Science ®Google Scholar
• Young J, Bouligand J, Francou B, et al. TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans. J Clin Endocrinol Metab. 2010;95:2287–2295.
   PubMed Web of Science ®Google Scholar
• Alçin E, Sahu A, Ramaswamy S, et al. Ovarian regulation of kisspeptin neurones in the arcuate nucleus of the rhesus monkey (Macaca mulatta). J Neuroendocrinol. 2013;25:488–496.
   PubMed Web of Science ®Google Scholar
• Rance NE, McMullen NT, Smialek JE, et al. Postmenopausal hypertrophy of neurons expressing the estrogen receptor gene in the human hypothalamus. J Clin Endocrinol Metab. 1990;71:79–85.
   PubMed Web of Science ®Google Scholar
• Rance NE, YOUNG WS. Hypertrophy and increased gene expression of neurons containing neurokinin-B and substance-P messenger ribonucleic acids in the hypothalami of postmenopausal women*. Endocrinology 1991;128:2239–2247.
   PubMed Web of Science ®Google Scholar
• Rance NE, Dacks PA, Mittelman-Smith MA, et al. Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: a novel hypothesis on the mechanism of hot flushes. Front Neuroendocrinol. 2013;34:211–227.
   PubMed Web of Science ®Google Scholar
• Rometo AM, Krajewski SJ, Lou Voytko M, et al. Hypertrophy and increased kisspeptin gene expression in the hypothalamic infundibular nucleus of postmenopausal women and ovariectomized monkeys. J Clin Endocrinol Metab. 2007;92:2744–2750.
   PubMed Web of Science ®Google Scholar
• Sandoval-Guzmán T, Stalcup ST, Krajewski SJ, et al. Effects of ovariectomy on the neuroendocrine axes regulating reproduction and energy balance in young cynomolgus macaques. J Neuroendocrinol. 2004;16:146–153.
   PubMed Web of Science ®Google Scholar
• Abel TW, Voytko ML, Rance NE. The effects of hormone replacement therapy on hypothalamic neuropeptide gene expression in a primate model of menopause. J Clin Endocrinol Metab. 1999;84:2111–2118.
   PubMed Web of Science ®Google Scholar
• Rance NE, Uswandi SV. Gonadotropin-releasing hormone gene expression is increased in the medial basal hypothalamus of postmenopausal women. J Clin Endocrinol Metab. 1996;81:3540.
   PubMed Web of Science ®Google Scholar
• Gore AC, Windsor-Engnell BM, Terasawa E. Menopausal increases in pulsatile gonadotropin-releasing hormone release in a nonhuman primate (Macaca mulatta). Endocrinology. 2004;145:4653–4659.
   PubMed Web of Science ®Google Scholar
• Rance NE. Menopause and the human hypothalamus: evidence for the role of kisspeptin/neurokinin B neurons in the regulation of estrogen negative feedback. Peptides. 2009;30:111–122.
   PubMed Web of Science ®Google Scholar
• Skorupskaite K, George JT, Veldhuis JD, et al. Neurokinin 3 receptor antagonism reveals roles for neurokinin B in the regulation of gonadotropin secretion and hot flashes in postmenopausal women. Neuroendocrinology. 2017;106:148–157.
   PubMed Web of Science ®Google Scholar
• Gill S, Sharpless JL, Rado K, et al. Evidence that GnRH decreases with gonadal steroid feedback but increases with age in postmenopausal women. J Clin Endocrinol Metab. 2002;87:2290–2296.
   PubMed Web of Science ®Google Scholar
• Goodman RL, Coolen LM, Anderson GM, et al. Evidence that dynorphin plays a major role in mediating progesterone negative feedback on gonadotropin-releasing hormone neurons in sheep. Endocrinology. 2004;145:2959–2967.
   PubMed Web of Science ®Google Scholar
• Rometo AM, Rance NE. Changes in prodynorphin gene expression and neuronal morphology in the hypothalamus of postmenopausal women. J Neuroendocrinol. 2008;20:1376–1381.
   PubMed Web of Science ®Google Scholar
• Ruka KA, Burger LL, Moenter SM. Regulation of arcuate neurons coexpressing kisspeptin, neurokinin B, and dynorphin by modulators of neurokinin 3 and κ-opioid receptors in adult male mice. Endocrinology. 2013;154:2761–2771.
   PubMed Web of Science ®Google Scholar
• Casper RF, Yen SS, Wilkes MM. Menopausal flushes: a neuroendocrine link with pulsatile luteinizing hormone secretion. Science. 1979;205:823–825.
   PubMed Web of Science ®Google Scholar
• Santoro N, Banwell T, Tortoriello D, et al. Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women. Am J Obstet Gynecol. 1998;178:732–741.
   PubMed Web of Science ®Google Scholar
• Mulley G, Mitchell JR, Tattersall RB. Hot flushes after hypophysectomy. Br Med J. 1977;2:1062.
   PubMedGoogle Scholar
• DeFazio J, Meldrum DR, Laufer L, et al. Induction of hot flashes in premenopausal women treated with a long-acting GnRH agonist. J Clin Endocrinol Metab. 1983;56:445–448.
   PubMed Web of Science ®Google Scholar
• Casper RF, Yen SSC. Neuroendocrinology of menopausal flushes: an hypothesis of flush mechanism. Clin Endocrinol (Oxf). 1985;22:293–312.
   PubMed Web of Science ®Google Scholar
• Gambone J, Meldrum DR, Laufer L, et al. Further delineation of hypothalamic dysfunction responsible for menopausal hot flashes. J Clin Endocrinol Metab. 1984;59:1097–1102.
   PubMed Web of Science ®Google Scholar
• Schwanzel-Fukuda M, Bick D, Pfaff DW. Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Brain Res Mol Brain Res. 1989;6:311–326.
   PubMedGoogle Scholar
• Nakamura K, Morrison SF. A thermosensory pathway mediating heat-defense responses. Proc Natl Acad Sci USA. 2010;107:8848–8853.
   PubMed Web of Science ®Google Scholar
• Jayasena CN, Comninos AN, Stefanopoulou E, et al. Neurokinin B administration induces hot flushes in women. Sci Rep. 2015;5:8466.
   PubMed Web of Science ®Google Scholar
• Navarro VM, Castellano JM, McConkey SM, et al. Interactions between kisspeptin and neurokinin B in the control of GnRH secretion in the female rat. Am J Physiol Endocrinol Metab. 2011;300:E202–E210.
   PubMed Web of Science ®Google Scholar
• Endo N, Tanaka T. Effects of senktide, a neurokinin 3 receptor agonist, on luteinizing hormone secretion and follicular development in anestrous Shiba goats: a pilot study. BMC Res Notes. 2014;7:773.
   PubMedGoogle Scholar
• Endo N, Rahayu LP, Ito Y, et al. Ovarian and hormonal responses to single or continuous peripheral administration of senktide, a neurokinin 3 receptor agonist, during the follicular phase in goats. Domest Anim Endocrinol. 2015;53:136–143.
   PubMed Web of Science ®Google Scholar
• Dacks PA, Krajewski SJ, Rance NE. Activation of neurokinin 3 receptors in the median preoptic nucleus decreases core temperature in the rat. Endocrinology. 2011;152:4894–4905.
   PubMed Web of Science ®Google Scholar
• Mittelman-Smith MA, Williams H, Krajewski-Hall SJ, et al. Role for kisspeptin/neurokinin B/dynorphin (KNDy) neurons in cutaneous vasodilatation and the estrogen modulation of body temperature. Proc Natl Acad Sci. 2012;109:19846–19851.
   PubMed Web of Science ®Google Scholar
• Lecci A, Maggi CA. Peripheral tachykinin receptors as potential therapeutic targets in visceral diseases. Expert Opin Ther Targets. 2003;7:343–362.
   PubMed Web of Science ®Google Scholar
• Skorupskaite K, George JT, Veldhuis JD, et al. Neurokinin B regulates gonadotropin secretion, ovarian follicle growth and the timing of ovulation in healthy women. J Clin Endocrinol Metab. 2017;103:95–104.
   Web of Science ®Google Scholar